• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较和分析现有针对病毒性心肌炎的单味中药策略。

Comparison and Analysis on the Existing Single-Herbal Strategies against Viral Myocarditis.

机构信息

Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, No. 10 Poyanghu Road, Tianjin 301617, China.

School of Chemical Engineering and Technology, Tianjin University, No. 135 Yaguan Road, Tianjin 300350, China.

出版信息

Genet Res (Camb). 2021 Aug 7;2021:9952620. doi: 10.1155/2021/9952620. eCollection 2021.

DOI:10.1155/2021/9952620
PMID:34456633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8371739/
Abstract

PURPOSE

Herbal medicine is one of crucial symbols of Chinese national medicine. Investigation on molecular responses of different herbal strategies against viral myocarditis is immeasurably conducive to targeting drug development in the current international absence of miracle treatment.

METHODS

Literature retrieval platforms were applied in the collection of existing empirical evidences for viral myocarditis-related single-herbal strategies. SwissTargetPrediction, Metascape, and Discovery Studio coordinating with multidatabases investigated underlying target genes, interactive proteins, and docking molecules in turn.

RESULTS

Six single-herbal medicines consisting of Huangqi (), Yuganzi (), Kushen (), Jianghuang (), Chaihu (), and Jixueteng () meet the requirement. There were 11 overlapped and 73 unique natural components detected in these herbs. SLC6A2, SLC6A4, NOS2, PPARA, PPARG, ACHE, CYP2C19, CYP51A1, and CHRM2 were equally targeted by six herbs and identified as viral myocarditis-associated symbols. MCODE algorithm exposed the hub role of SRC and EGFR in strategies without Jianghuang. Subsequently, we learned intermolecular interactions of herbal components and their targeting heart-tissue-specific CHRM2, FABP3, TNNC1, TNNI3, TNNT2, and SCN5A and cardiac-myocytes-specific IL6, MMP1, and PLAT coupled with viral myocarditis. Ten interactive characteristics such as -alkyl and van der Waals were modeled in which ARG111, LYS253, ILE114, and VAL11 on cardiac troponin (TNNC1-TNNI3-TNNT2) and ARG208, ASN106, and ALA258 on MMP1 fulfilled potential communicating anchor with ellagic acid, 5, 9-dihydroxymatrine, and leachianone g via hydrogen bond and hydrophobic interaction, respectively.

CONCLUSIONS

The comprehensive outcomes uncover differences and linkages between six herbs against viral myocarditis through component and target analysis, fostering development of drugs.

摘要

目的

草药是中医药的重要标志之一。研究不同草药策略对病毒性心肌炎的分子反应对于当前国际上缺乏特效治疗方法的靶向药物开发具有重要意义。

方法

应用文献检索平台收集病毒性心肌炎相关单味草药策略的现有实证证据。瑞士靶向预测、Metascape 和 Discovery Studio 与多数据库合作,依次研究潜在的靶基因、相互作用蛋白和对接分子。

结果

六种单味草药(黄芪、预知子、苦参、姜黄、柴胡和鸡血藤)符合要求。这些草药中检测到 11 个重叠和 73 个独特的天然成分。SLC6A2、SLC6A4、NOS2、PPARA、PPARG、ACHE、CYP2C19、CYP51A1 和 CHRM2 被六种草药共同靶向,并被鉴定为病毒性心肌炎相关符号。MCODE 算法暴露了没有姜黄的策略中 SRC 和 EGFR 的枢纽作用。随后,我们了解了草药成分与其靶向心脏组织特异性 CHRM2、FABP3、TNNC1、TNNI3、TNNT2 和 SCN5A 以及心脏肌细胞特异性 IL6、MMP1 和 PLAT 之间的分子间相互作用,以及与病毒性心肌炎相关的相互作用。在模型中模拟了十个相互作用特征,如 -烷基和范德华力,其中心脏肌钙蛋白(TNNC1-TNNI3-TNNT2)上的 ARG111、LYS253、ILE114 和 VAL11 和 MMP1 上的 ARG208、ASN106 和 ALA258 与鞣花酸、5,9-二羟基苦参碱和漆酮 g 分别通过氢键和疏水相互作用满足潜在的通信锚。

结论

通过成分和靶点分析,全面的结果揭示了六种草药治疗病毒性心肌炎的差异和联系,为药物开发提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f3/8371739/e7c904f1091f/GR2021-9952620.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f3/8371739/974522e16f24/GR2021-9952620.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f3/8371739/0be70c557263/GR2021-9952620.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f3/8371739/c9e1706dbbd1/GR2021-9952620.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f3/8371739/e7c904f1091f/GR2021-9952620.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f3/8371739/974522e16f24/GR2021-9952620.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f3/8371739/0be70c557263/GR2021-9952620.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f3/8371739/c9e1706dbbd1/GR2021-9952620.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f3/8371739/e7c904f1091f/GR2021-9952620.004.jpg

相似文献

1
Comparison and Analysis on the Existing Single-Herbal Strategies against Viral Myocarditis.比较和分析现有针对病毒性心肌炎的单味中药策略。
Genet Res (Camb). 2021 Aug 7;2021:9952620. doi: 10.1155/2021/9952620. eCollection 2021.
2
Herbal medicines for viral myocarditis.用于治疗病毒性心肌炎的草药
Cochrane Database Syst Rev. 2013 Aug 28(8):CD003711. doi: 10.1002/14651858.CD003711.pub5.
3
Herbal medicines for viral myocarditis.用于治疗病毒性心肌炎的草药
Cochrane Database Syst Rev. 2012 Nov 14;11:CD003711. doi: 10.1002/14651858.CD003711.pub4.
4
WITHDRAWN: Herbal medicines for viral myocarditis.撤回:用于病毒性心肌炎的草药。
Cochrane Database Syst Rev. 2016 May 3;2016(5):CD003711. doi: 10.1002/14651858.CD003711.pub6.
5
[Experimental research progress of treating viral myocarditis by Chinese medicine].[中医药治疗病毒性心肌炎的实验研究进展]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Oct;33(10):1438-40.
6
Prof. Cao Hongxin's experience in treating viral myocarditis with xuefu zhuyu tang.曹洪欣教授运用血府逐瘀汤治疗病毒性心肌炎的经验
J Tradit Chin Med. 2003 Mar;23(1):14-6.
7
[Comparative clinical observation on effects of shensu injection and vitamin C in treating acute viral myocarditis].参苏注射液与维生素C治疗急性病毒性心肌炎的疗效对比临床观察
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Feb;22(2):138-9.
8
Successful treatment of complete left bundle branch block complicating acute viral myocarditis employing Chinese herbs.运用中药成功治疗并发急性病毒性心肌炎的完全性左束支传导阻滞
Am J Chin Med. 1986;14(3-4):124-30. doi: 10.1142/S0192415X8600020X.
9
Advances in the Traditional Chinese Medicine-Based Management of Viral Myocarditis.基于中医的病毒性心肌炎管理进展
Cell Biochem Biophys. 2015 Sep;73(1):237-43. doi: 10.1007/s12013-015-0620-x.
10
[Therapeutic effect of kangke injection on viral myocarditis and its anticoxsackie virus mechanism].康可注射液对病毒性心肌炎的治疗作用及其抗柯萨奇病毒机制
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Apr;17(4):207-9.

引用本文的文献

1
Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation.通过网络药理学分析和实验验证探索肝胃康片作为非酒精性脂肪性肝病候选药物
Front Pharmacol. 2022 Jun 14;13:893336. doi: 10.3389/fphar.2022.893336. eCollection 2022.

本文引用的文献

1
MicroRNA-30a-5p silencing polarizes macrophages toward M2 phenotype to alleviate cardiac injury following viral myocarditis by targeting SOCS1.MicroRNA-30a-5p 沉默使巨噬细胞向 M2 表型极化,通过靶向 SOCS1 减轻病毒性心肌炎后的心脏损伤。
Am J Physiol Heart Circ Physiol. 2021 Apr 1;320(4):H1348-H1360. doi: 10.1152/ajpheart.00431.2020. Epub 2021 Jan 8.
2
Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics.病毒性心肌炎:1917-2020:从甲型流感到 COVID-19 大流行。
Trends Cardiovasc Med. 2021 Apr;31(3):163-169. doi: 10.1016/j.tcm.2020.12.007. Epub 2020 Dec 29.
3
Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.
比较过氧化物酶体增殖物激活受体配体作为炎症消退的调节剂,通过它们对星形胶质细胞细胞因子和氧化脂类释放的影响。
Int J Mol Sci. 2020 Dec 16;21(24):9577. doi: 10.3390/ijms21249577.
4
FKBP22 from the psychrophilic bacterium Shewanella sp. SIB1 selectively binds to the reduced state of insulin to prevent its aggregation.来自嗜冷菌希瓦氏菌 SIB1 的 FKBP22 选择性结合到还原态的胰岛素以防止其聚集。
Cell Stress Chaperones. 2021 Mar;26(2):377-386. doi: 10.1007/s12192-020-01183-0. Epub 2020 Nov 27.
5
Could chroman-4-one derivative be a better inhibitor of PTR1? - Reason for the identified disparity in its inhibitory potency in Trypanosoma brucei and Leishmania major.色满酮衍生物是否能成为 PTR1 的更好抑制剂?——在布鲁氏锥虫和利什曼原虫中其抑制效力存在差异的原因。
Comput Biol Chem. 2021 Feb;90:107412. doi: 10.1016/j.compbiolchem.2020.107412. Epub 2020 Nov 7.
6
Long non-coding RNA MEG3 inhibits M2 macrophage polarization by activating TRAF6 via microRNA-223 down-regulation in viral myocarditis.长链非编码 RNA MEG3 通过下调 microRNA-223 激活 TRAF6 抑制病毒性心肌炎中 M2 型巨噬细胞极化。
J Cell Mol Med. 2020 Nov;24(21):12341-12354. doi: 10.1111/jcmm.15720. Epub 2020 Oct 13.
7
Coronavirus-induced myocarditis: A meta-summary of cases.冠状病毒性心肌炎:病例汇总分析。
Heart Lung. 2020 Nov-Dec;49(6):681-685. doi: 10.1016/j.hrtlng.2020.08.013. Epub 2020 Aug 20.
8
SARS-CoV-2 Fulminant Myocarditis.严重急性呼吸综合征冠状病毒2型暴发性心肌炎
JACC Case Rep. 2020 Jul 15;2(9):1342-1346. doi: 10.1016/j.jaccas.2020.05.060. Epub 2020 Jun 5.
9
Acute perimyocarditis with cardiac tamponade in COVID-19 infection without respiratory disease.新型冠状病毒肺炎(COVID-19)感染且无呼吸道疾病情况下伴心脏压塞的急性心包心肌炎
BMJ Case Rep. 2020 Aug 19;13(8):e236218. doi: 10.1136/bcr-2020-236218.
10
Intrinsic activation of cardiosphere-derived cells enhances myocardial repair.心脏球来源细胞的内在激活增强心肌修复。
J Thorac Cardiovasc Surg. 2022 Apr;163(4):1479-1490.e5. doi: 10.1016/j.jtcvs.2020.05.040. Epub 2020 May 29.